Beyond the hashtags, the latest research does suggest that IBS is more prevalent—affecting 6.1% of people in the U.S.—than ...

The most recent addition to this armamentarium is an antibody drug, dinutuximab, which recognizes a specific protein on neuroblastoma cells and marks them for destruction by the immune system.

In summary, the clinician currently has access to multiple tools in the therapeutic armamentarium for maintaining sinus rhythm in patients with AF. In addition to drugs, catheter ablation to cure ...

A wide selection of therapies are available to treat advanced prostate cancer, but the optimal treatment strategy is unknown.

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the ...

We have reached a point of impasse in treatment of preterm infants and many of their illnesses. Many of the problems we see ...

New monoclonal antibodies directed against new targets are under development, and hopefully several will emerge as alternative agents in the armamentarium against RA. Monoclonal antibodies and ...

To cure sometimes, to relieve often, to comfort always.” What we strive to do has not changed since Dr Edward Trudeau's aphorism in the 19th century—but our therapeutic armamentarium has. For many ...

Tocilizumab -- an interleukin (IL)-6 receptor inhibitor -- was approved by the FDA in 2017 for the treatment of severe or ...

Olorofim is licensed in Europe and Asia to Japanese pharma Shionogi, which paid $100 million upfront for rights to the drug ...

Silverman, Richard B Candiotti, Keith A and Gitlin, Melvin C 2012. Tapentadol Extended-Release: A Recent Addition to our Analgesic Armamentarium. Pain Management, Vol ...

In addition to our full armamentarium of medical devices and emergency management solutions, we've introduced innovative technologies to address the physical and mental wellness of our nation's ...